News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Reliant Pharmaceuticals, Inc. Withdraws IPO Plans
November 21, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Nov 21 (Reuters) - Reliant Pharmaceuticals Inc filed with U.S. regulators to withdraw the planned initial public offering of its common stock.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Gene editing
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
December 1, 2025
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Avidity Played Hardball To Land Favorable Terms in $12B Novartis Deal
November 25, 2025
·
3 min read
·
Annalee Armstrong
Drug Development
CRO Boom in APAC Region, With China at the Forefront
November 19, 2025
·
5 min read
·
Jennifer Smith-Parker
Mergers & acquisitions
Five Assets Given Away by Big Pharma That Ultimately Got Bought for Billions
November 19, 2025
·
9 min read
·
Tristan Manalac
